Hikma Pharmaceuticals (CHIX:HIKL) Ending Cash Position : £149 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Hikma Pharmaceuticals Ending Cash Position?

Hikma Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 was £149 Mil.

Hikma Pharmaceuticals's quarterly Ending Cash Position increased from Dec. 2023 (£162 Mil) to Jun. 2024 (£185 Mil) but then declined from Jun. 2024 (£185 Mil) to Dec. 2024 (£149 Mil).

Hikma Pharmaceuticals's annual Ending Cash Position declined from Dec. 2022 (£222 Mil) to Dec. 2023 (£162 Mil) and declined from Dec. 2023 (£162 Mil) to Dec. 2024 (£149 Mil).

Hikma Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Hikma Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Ending Cash Position Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

240.31

320.35

221.67

161.95

148.71

Hikma Pharmaceuticals Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															221.67	215.42	161.95	185.50	148.71

Hikma Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Hikma Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	162.155	+	-13.447
	=	149

Hikma Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	186.676	+	-37.968
	=	149

Hikma Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikma Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (CHIX:HIKl) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

HKMPY:USA HKMPF:USA HIK:UK H5P:Germany

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.

Hikma Pharmaceuticals Headlines

No Headlines